Literature DB >> 11865059

Critical residues within the BTB domain of PLZF and Bcl-6 modulate interaction with corepressors.

Ari Melnick1, Graeme Carlile, K Farid Ahmad, Chih-Li Kiang, Connie Corcoran, Vivian Bardwell, Gilbert G Prive, Jonathan D Licht.   

Abstract

The PLZF (promyelocytic leukemia zinc finger) transcriptional repressor, when fused to retinoic acid receptor alpha (RARalpha), causes a refractory form of acute promyelocytic leukemia. The highly conserved N-terminal BTB (bric a brac, tramtrack, broad complex)/POZ domain of PLZF plays a critical role in this disease, since it is required for transcriptional repression by the PLZF-RARalpha fusion protein. The crystal structure of the PLZF BTB domain revealed an obligate homodimer with a highly conserved charged pocket formed by apposition of the two monomers. An extensive structure-function analysis showed that the charged pocket motif plays a major role in transcriptional repression by PLZF. We found that mutations of the BTB domain that neutralize key charged pocket residues did not disrupt dimerization, yet abrogated the ability of PLZF to repress transcription and led to the loss of interaction with N-CoR, SMRT, and histone deacetylases (HDACs). We extended these studies to the Bcl-6 protein, which is linked to the pathogenesis of non-Hodgkin's lymphomas. In this case, neutralizing the charged pocket also resulted in loss of repression and corepressor binding. Experiments with purified protein showed that corepressor-BTB interactions were direct. A comparison of the PLZF, Bcl-6, and the FAZF (Fanconi anemia zinc finger)/ROG protein shows that variations in the BTB pocket result in differential affinity for corepressors, which predicts the potency of transcriptional repression. Thus, the BTB pocket represents a molecular structure involved in recruitment of transcriptional repression complexes to target promoters.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11865059      PMCID: PMC135611          DOI: 10.1128/MCB.22.6.1804-1818.2002

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  54 in total

1.  Tramtrack69 is positively and autonomously required for Drosophila photoreceptor development.

Authors:  Z C Lai; Y Li
Journal:  Genetics       Date:  1999-05       Impact factor: 4.562

2.  Components of the SMRT corepressor complex exhibit distinctive interactions with the POZ domain oncoproteins PLZF, PLZF-RARalpha, and BCL-6.

Authors:  C W Wong; M L Privalsky
Journal:  J Biol Chem       Date:  1998-10-16       Impact factor: 5.157

3.  The BCL-6 POZ domain and other POZ domains interact with the co-repressors N-CoR and SMRT.

Authors:  K D Huynh; V J Bardwell
Journal:  Oncogene       Date:  1998-11-12       Impact factor: 9.867

4.  Co-operative DNA binding by GAGA transcription factor requires the conserved BTB/POZ domain and reorganizes promoter topology.

Authors:  K R Katsani; M A Hajibagheri; C P Verrijzer
Journal:  EMBO J       Date:  1999-02-01       Impact factor: 11.598

5.  A novel BTB/POZ transcriptional repressor protein interacts with the Fanconi anemia group C protein and PLZF.

Authors:  M E Hoatlin; Y Zhi; H Ball; K Silvey; A Melnick; S Stone; S Arai; N Hawe; G Owen; A Zelent; J D Licht
Journal:  Blood       Date:  1999-12-01       Impact factor: 22.113

6.  Structure-function studies of the BTB/POZ transcriptional repression domain from the promyelocytic leukemia zinc finger oncoprotein.

Authors:  X Li; H Peng; D C Schultz; J M Lopez-Guisa; F J Rauscher; R Marmorstein
Journal:  Cancer Res       Date:  1999-10-15       Impact factor: 12.701

7.  The promyelocytic leukemia zinc finger (PLZF) protein binds DNA in a high molecular weight complex associated with cdc2 kinase.

Authors:  H J Ball; A Melnick; R Shaknovich; R A Kohanski; J D Licht
Journal:  Nucleic Acids Res       Date:  1999-10-15       Impact factor: 16.971

8.  Evolutionary divergence in the broad complex, tramtrack and bric à brac/poxviruses and zinc finger domain from the candidate tumor suppressor gene hypermethylated in cancer.

Authors:  C Guerardel; S Deltour; D Leprince
Journal:  FEBS Lett       Date:  1999-05-28       Impact factor: 4.124

9.  Leukemia translocation protein PLZF inhibits cell growth and expression of cyclin A.

Authors:  P L Yeyati; R Shaknovich; S Boterashvili; J Li; H J Ball; S Waxman; K Nason-Burchenal; E Dmitrovsky; A Zelent; J D Licht
Journal:  Oncogene       Date:  1999-01-28       Impact factor: 9.867

10.  Crystal structure of the BTB domain from PLZF.

Authors:  K F Ahmad; C K Engel; G G Privé
Journal:  Proc Natl Acad Sci U S A       Date:  1998-10-13       Impact factor: 11.205

View more
  73 in total

1.  MicroRNA (miRNA)-mediated interaction between leukemia/lymphoma-related factor (LRF) and alternative splicing factor/splicing factor 2 (ASF/SF2) affects mouse embryonic fibroblast senescence and apoptosis.

Authors:  Lorena Verduci; Marcella Simili; Milena Rizzo; Alberto Mercatanti; Monica Evangelista; Laura Mariani; Giuseppe Rainaldi; Letizia Pitto
Journal:  J Biol Chem       Date:  2010-10-04       Impact factor: 5.157

2.  The Mod(mdg4) component of the Su(Hw) insulator inserted in the P transposon can repress its mobility in Drosophila melanogaster.

Authors:  Marina Karakozova; Ekaterina Savitskaya; Larisa Melnikova; Aleksandr Parshikov; Pavel Georgiev
Journal:  Genetics       Date:  2004-07       Impact factor: 4.562

Review 3.  POK/ZBTB proteins: an emerging family of proteins that regulate lymphoid development and function.

Authors:  Sung-Uk Lee; Takahiro Maeda
Journal:  Immunol Rev       Date:  2012-05       Impact factor: 12.988

4.  Aberrant chromatin remodeling by retinoic acid receptor alpha fusion proteins assessed at the single-cell level.

Authors:  Jihui Qiu; Ying Huang; Guoqiang Chen; Zhu Chen; David J Tweardy; Shuo Dong
Journal:  Mol Biol Cell       Date:  2007-08-01       Impact factor: 4.138

5.  ZENON, a novel POZ Kruppel-like DNA binding protein associated with differentiation and/or survival of late postmitotic neurons.

Authors:  Hélène Kiefer; Fabienne Chatail-Hermitte; Philippe Ravassard; Elisa Bayard; Isabelle Brunet; Jacques Mallet
Journal:  Mol Cell Biol       Date:  2005-03       Impact factor: 4.272

6.  DBC2 is essential for transporting vesicular stomatitis virus glycoprotein.

Authors:  Faith K Chang; Noriko Sato; Noriko Kobayashi-Simorowski; Takashi Yoshihara; Jennifer L Meth; Masaaki Hamaguchi
Journal:  J Mol Biol       Date:  2006-09-15       Impact factor: 5.469

7.  Histone acetyltransferase activity of p300 is required for transcriptional repression by the promyelocytic leukemia zinc finger protein.

Authors:  Fabien Guidez; Louise Howell; Mark Isalan; Marek Cebrat; Rhoda M Alani; Sarah Ivins; Itsaso Hormaeche; Melanie J McConnell; Sarah Pierce; Philip A Cole; Jonathan Licht; Arthur Zelent
Journal:  Mol Cell Biol       Date:  2005-07       Impact factor: 4.272

8.  Structure of the human Nac1 POZ domain.

Authors:  Mark A Stead; Stephen B Carr; Stephanie C Wright
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2009-04-24

Review 9.  The biology of human lymphoid malignancies revealed by gene expression profiling.

Authors:  Louis M Staudt; Sandeep Dave
Journal:  Adv Immunol       Date:  2005       Impact factor: 3.543

Review 10.  Therapeutic targeting of the BCL6 oncogene for diffuse large B-cell lymphomas.

Authors:  Samir Parekh; Gilbert Privé; Ari Melnick
Journal:  Leuk Lymphoma       Date:  2008-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.